(Q39995957)

16 September 2017

title

Monitoring of FLT3 phosphorylation status and its response to drugs by flow cytometry in AML blast cells (English)

1 reference

16 September 2017

1 reference

1 reference

8

Giovanni Martinelli

1 reference

16 September 2017

7

Michele Baccarani

1 reference

16 September 2017

6

Sergio Storti

1 reference

16 September 2017

2

Michela Palmisano

1 reference

16 September 2017

1

Tiziana Grafone

1 reference

16 September 2017

3

Chiara Nicci

1 reference

16 September 2017

author name string

Alberto Maria Martelli

series ordinal

4

1 reference

16 September 2017

Ottaviani Emanuela

series ordinal

5

1 reference

16 September 2017

language of work or name

1 reference

1 September 2008

1 reference

16 September 2017

published in

Hematological Oncology

1 reference

16 September 2017

volume

26

1 reference

16 September 2017

issue

3

1 reference

16 September 2017

page(s)

159-166

1 reference

describes a project that uses

16 September 2017

1 reference

FLT3 mutations: biology and treatment

1 reference

The roles of FLT3 in hematopoiesis and leukemia

21 January 2018

1 reference

7 January 2021

FLT3: ITDoes matter in leukemia

1 reference

7 January 2021

Role of FLT3 in leukemia

1 reference

7 January 2021

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

7 January 2021

Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples

1 reference

7 January 2021

Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia

1 reference

7 January 2021

Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC.

1 reference

7 January 2021

Autologous peripheral blood stem cell transplantation in acute myeloblastic leukaemia and myelodysplastic syndrome patients: evaluation of tumour cell contamination of leukaphereses by cytogenetic and molecular methods

1 reference

7 January 2021

The structural basis for autoinhibition of FLT3 by the juxtamembrane domain

1 reference

7 January 2021

FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells

1 reference

7 January 2021

Novel FLT3 tyrosine kinase inhibitors

1 reference

7 January 2021

Developing target therapy against oncogenic tyrosine kinase in myeloid maliganacies

1 reference

7 January 2021

Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling

1 reference

7 January 2021

Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors.

1 reference

7 January 2021

Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry

1 reference

7 January 2021

Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level

1 reference

7 January 2021

Single cell profiling of potentiated phospho-protein networks in cancer cells.

1 reference

7 January 2021

Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia

1 reference

7 January 2021

Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma.

1 reference

7 January 2021

Detection of serine 473 phosphorylated Akt in acute myeloid leukaemia blasts by flow cytometry

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.854

1 reference

16 September 2017

1 reference